Agreement between self-reported breast cancer treatment and medical records in a population-based breast cancer family registry
Agreement between self-reported breast cancer treatment and medical records in a population-based breast cancer family registry
复制标题
DOI：
10.1200/jco.2005.03.002
复制
发表时间：
2005-07-20
影响因子：
45.3
通讯作者：
Hopper, JL
中科院分区：
文献类型：
--
作者：
Phillips, KA;Milne, RL;Hopper, JL
PurposeAlthough自我报告的数据收集在一些大型流行病学研究乳腺癌的治疗，其准确性是unknown.MethodsAs的一部分，人口为基础的乳腺癌家族登记处，调查问卷的初始乳腺癌治疗和随后的复发邮寄给澳大利亚妇女诊断1991年和1998年之间。这些自我报告的数据进行了验证对医疗记录为895 women.ResultsThe中位回忆期为3.2年，平均年龄在诊断为44岁，和81%的妇女有早期乳腺癌。两个数据源之间关于治疗类型的一般问题的一致性非常高（手术、放疗、化疗和激素治疗分别为100%、99%、99%和94%）。关于接受的每种治疗的细节的更具体的问题，同意率为：对于放射治疗，乳房和胸壁放射分别为96%和99%;对于手术，乳房肿瘤切除术、乳房切除术和淋巴结清扫术分别为83%、97%和88%;对于激素治疗，他莫昔芬为94%，化疗为76%至93%。有97%的人同意是否有复发，复发的位置是至少90%的所有网站的协议。在诊断阶段的协议是62%，与差异主要是由于妇女与locoregional疾病不正确地报告遥远的spread.ConclusionThis自我报告的问卷调查可以用来收集准确的数据，初步乳腺癌治疗和复发的广泛类别，甚至更详细的信息，治疗的细节和复发的网站。
PurposeAlthough self-report data on treatment for breast cancer are collected in some large epidemiologic studies, their accuracy is unknown.MethodsAs part of a population-based Breast Cancer Family Registry, questionnaires on initial breast cancer treatment and subsequent recurrence were mailed to Australian women diagnosed between 1991 and 1998. These self-report data were validated against medical records for 895 women.ResultsThe median recall period was 3.2 years, mean age at diagnosis was 44 years, and 81% of women had early-stage breast cancer. Agreement between the two data sources was very high for general questions about type of treatment (100%, 99%, 99%, and 94% for surgery, radiotherapy, chemotherapy, hormonal therapy, respectively). For more specific questions about details of each treatment received, agreement was: for radiation therapy, 96% and 99% for radiation to the breast and chest wall, respectively; for surgery, 83%, 97%, and 88% for lumpectomy, mastectomy, and lymph node dissection, respectively, for hormonal therapy, 94% for tamoxifen, and for chemotherapy, range between 76% and 93%. There was 97% agreement about whether there had been a recurrence, and agreement about the location of recurrence was at least 90% for all sites. Agreement regarding stage at diagnosis was 62%, with discrepancies mostly due to women with locoregional disease incorrectly reporting distant spread.ConclusionThis self-report questionnaire can be used to collect accurate data on broad categories of initial breast cancer treatment and recurrence, and even for more detailed information on specifics of treatment and site of recurrence.